• Jiangsu Hengrui launched an A-share buyback plan of RMB 1-2 billion via centralized price bidding.
• Repurchases to fund an A-share employee stock ownership scheme; maximum price set at RMB 81.78 per share.
• Program runs up to 12 months from Aug. 19, 2026; estimated 12,227,900-24,455,900 shares, or 0.18%-0.37% of share capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12291176), on August 19, 2026, and is solely responsible for the information contained therein.